Anti-Angiogenic
Showing 9926 - 9950 of >10,000
Dietary Fat Load and Physical Exercise on Flexibility and
Completed
- Ectopic Lipids
- +4 more
- Fat diet
- 2h standardized aerobic exercise
-
Berne, SwitzerlandDepartment of Endocrinology, Diabetes and Clinical Nutrition, Un
Oct 8, 2018
Inflammatory Markers Following Pulmonary Rehabilitation
Completed
- COPD
- Physical activity monitoring
-
Lincoln, Lincolnshire, United Kingdom
- +2 more
Oct 8, 2018
Correlation Between PT and INR to Factor 7
Unknown status
- Epistaxis
- ENT Disorder
- no intervention
- (no location specified)
Dec 25, 2018
Anti-insulin-like Growth Factor-1 Receptor Antibodies in Graves'
Completed
- Graves Ophthalmopathy
- +2 more
- Serum antibodies against the IGF-1R
-
Pisa, ItalyEndocrinology Unit I, University of Pisa
Jul 26, 2018
Complement-activating Anti-human Leucocyte Antigen Donor
Completed
- Organ Transplant Recipients
- Graft survival and/or Rejection appearance
- (no location specified)
Feb 15, 2018
Leukaemia, Myelocytic, Acute Trial in France, United States (GSK Biologicals' recombinant WT1 Antigen-Specific Cancer
Completed
- Leukaemia, Myelocytic, Acute
- GSK Biologicals' recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)
-
Tampa, Florida
- +9 more
Jan 8, 2018
Rheumatoid Arthritis Trial in Worldwide (LY2127399, Placebo)
Tuberculosis, Pulmonary, AIDS Trial in Shanghai (Rifampicin, Rifabutin)
Unknown status
- Tuberculosis, Pulmonary
- AIDS
-
Shanghai, Shanghai, ChinaShanghai Public Health Clinical Center
Apr 23, 2018
Type II Monocytes/Macrophages in Patients Receiving Gilenya.
Completed
- Multiple Sclerosis
-
Los Angeles, CaliforniaUniversity of Southern California, Department of Neurology
Aug 21, 2018
Mild Cognitive Impairment Trial in Singapore (ergothioneine, )
Unknown status
- Mild Cognitive Impairment
- ergothioneine
- placebo
-
Singapore, SingaporeNational University Cancer Institute, Singapore
Aug 19, 2018
Safety Study of Abatacept to Treat Rheumatoid Arthritis
Unknown status
- Rheumatoid Arthritis
- (no location specified)
Mar 26, 2018
HIV Trial in Toronto (alendronate/vitamin D)
Completed
- HIV
- alendronate/vitamin D
-
Toronto, Ontario, Canada
- +1 more
Apr 17, 2018
Healthy Trial in Unit 34, Surrey Technology Centre, Surrey Research Park (D-Gam® (human anti-D immunoglobulin), Rhophylac®
Completed
- Healthy
- D-Gam® (human anti-D immunoglobulin)
- Rhophylac® (human anti-D immunoglobulin)
-
Unit 34, Surrey Technology Centre, Surrey Research Park, Occam Road, Guildford, Surrey, United KingdomGuildford Clinical Pharmacology Unit
Mar 12, 2018
Chronic Pain Trial in Hong Kong (aromatherapy)
Completed
- Chronic Pain
- aromatherapy
-
Hong Kong, Hong KongThe Hong Kong Polytechnic University
Jan 23, 2019
HIV Infection Trial in Ottawa (Micronutrients and antioxidants, Multivitamins and minerals)
Completed
- HIV Infection
- Micronutrients and antioxidants
- Multivitamins and minerals
-
Ottawa, Ontario, CanadaThe Ottawa Hospital, General Campus
Apr 13, 2018
Acute ST Segment Elevation Myocardial Infarction, Acute Coronary Syndrome Trial in El Dorado (Ticagrelor, Clopidogrel)
Withdrawn
- Acute ST Segment Elevation Myocardial Infarction
- Acute Coronary Syndrome
-
El Dorado, ArkansasMedical Center of South Arkansas
Apr 2, 2018
Periodontal Diseases Trial (PeriActive)
Unknown status
- Periodontal Diseases
- PeriActive
- (no location specified)
Mar 12, 2018
Lung Cancer, NSCLC Trial in Shenzhen (LC-CTLs)
Withdrawn
- Lung Cancer
- NSCLC
- LC-CTLs
-
Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
Mar 25, 2018
Inflammation, Insulin Sensitivity Trial in Baltimore (Weight Loss, Aerobic Exercise Training)
Completed
- Inflammation
- Insulin Sensitivity
- Weight Loss
- Aerobic Exercise Training
-
Baltimore, MarylandBaltimore VA Medical Center VA Maryland Health Care System, Balt
Mar 29, 2018
Dietary Modification Trial in Murcia (Oxxynea®, Placebo)
Completed
- Dietary Modification
- Oxxynea®
- Placebo
-
Murcia, SpainUCAM (Universidad Catolica San Antonio de Murcia)
Mar 12, 2018
Kidney Failure, Chronic Trial in Baltimore (Thymoglobulin, Daclizumab, Plasmapheresis)
Completed
- Kidney Failure, Chronic
- Thymoglobulin
- +7 more
-
Baltimore, MarylandThe Johns Hopkins University, School of Medicine
Dec 19, 2017